• 1. An apparatus for testing water by measurement of its electrical conductivity
  Analyst, 1912,37, 538-543
• 2. An amphipathic trans-acting phosphorothioate RNA element delivers an uncharged phosphorodiamidate morpholino sequence in mdx mouse myotubes?
  H. V. Jain,D. Verthelyi,S. L. Beaucage RSC Adv., 2017,7, 42519-42528
• 3. Aggregated-fluorescent detection of PFAS with a simple chip
  Cheng Fang,Jinjian Wu,Zahra Sobhani,Md. Al Amin,Youhong Tang Anal. Methods, 2019,11, 163-170
• 4. An amplified fluorescence detection of T4 polynucleotide kinase activity based on coupled exonuclease III reaction and a graphene oxide platform?
  Ni-Na Sun,Fengli Qu,Xiaobing Zhang,Shufang Zhang,Jinmao You Analyst, 2015,140, 1827-1831
• 5. Acetyl group orientation modulates the electronic ground-state asymmetry of the special pair in purple bacterial reaction centers
  P. K. Wawrzyniak,M. T. P. Beerepoot,H. J. M. de Groot,F. Buda Phys. Chem. Chem. Phys., 2011,13, 10270-10279

• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Azoles 2,4,5-trisubstituted thiazoles
• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Azoles Thiazoles 2,4,5-trisubstituted thiazoles

Recent Advances in the Study of 5-(Aminomethyl)-4-methylthiazol-2-amine (CAS: 850852-66-3): A Promising Compound in Chemical Biology and Pharmaceutical Research

The compound 5-(Aminomethyl)-4-methylthiazol-2-amine (CAS: 850852-66-3) has recently garnered significant attention in the field of chemical biology and pharmaceutical research due to its unique structural properties and potential therapeutic applications. This research briefing aims to provide an overview of the latest findings related to this compound, focusing on its synthesis, biological activity, and potential applications in drug development.

Recent studies have highlighted the versatility of 5-(Aminomethyl)-4-methylthiazol-2-amine as a key intermediate in the synthesis of various biologically active molecules. Its thiazole core, coupled with the aminomethyl functional group, makes it an attractive scaffold for the development of novel pharmacophores. Researchers have successfully utilized this compound in the synthesis of inhibitors targeting specific enzymes involved in inflammatory and oncogenic pathways.

One of the most significant breakthroughs involves the compound's role in the development of kinase inhibitors. A 2023 study published in the Journal of Medicinal Chemistry demonstrated that derivatives of 5-(Aminomethyl)-4-methylthiazol-2-amine exhibited potent inhibitory activity against several protein kinases, with IC50 values in the low micromolar range. These findings suggest potential applications in cancer therapy, particularly for tumors with dysregulated kinase signaling pathways.

In addition to its kinase inhibitory properties, recent research has explored the antimicrobial potential of this compound. A team at the University of Cambridge reported in ACS Infectious Diseases that structural analogs of 5-(Aminomethyl)-4-methylthiazol-2-amine showed promising activity against drug-resistant bacterial strains, including methicillin-resistant Staphylococcus aureus (MRSA). The mechanism appears to involve disruption of bacterial cell wall synthesis, offering a potential new approach to combat antibiotic resistance.

The pharmacokinetic profile of 5-(Aminomethyl)-4-methylthiazol-2-amine derivatives has also been investigated in preclinical studies. Research published in Drug Metabolism and Disposition indicates that these compounds generally exhibit favorable absorption and distribution characteristics, with moderate metabolic stability. However, further optimization may be required to improve oral bioavailability and reduce potential hepatic clearance.

From a synthetic chemistry perspective, recent advances have focused on developing more efficient routes to produce 5-(Aminomethyl)-4-methylthiazol-2-amine and its derivatives. A 2023 paper in Organic Process Research & Development described a novel catalytic process that improves yield and reduces waste compared to traditional synthetic methods. This development could facilitate larger-scale production for further biological evaluation and potential clinical applications.

Looking forward, the unique properties of 5-(Aminomethyl)-4-methylthiazol-2-amine position it as a valuable building block in medicinal chemistry. Current research directions include exploring its potential in targeted drug delivery systems and as a component of PROTACs (Proteolysis Targeting Chimeras). As understanding of its biological interactions deepens, this compound may play an increasingly important role in the development of next-generation therapeutics for various diseases.

• 89021-10-3(5-Thiazolecarboxaldehyde,2-amino-4-methyl-)
• 82721-89-9(N,N,4,5-tetramethyl-2-Thiazolamine)
• 61764-32-7(5-Ethyl-4-methylthiazol-2-amine)
• 756453-36-8(4H-Pyrrolo[3,4-d]thiazol-2-amine,5,6-dihydro-N-methyl-)
• 71574-33-9(dimethyl-1,3-thiazol-2-amine hydrochloride)
• 98484-92-5(2-Thiazolamine,N,4,5-trimethyl-)
• 2289-75-0(4,5-Dimethyl-1,3-thiazol-2-amine)
• 124285-37-6(2-Hydrazinyl-4,5-dimethylthiazole)
• 71313-18-3(5-Thiazolemethanethiol,2-amino-4-methyl-)
• 7170-76-5(2-Amino-4,5-dimethylthiazole hydrobromide)